4//SEC Filing
Delaney Brendan 4
Accession 0001209191-23-014589
CIK 0001422142other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:05 PM ET
Size
6.2 KB
Accession
0001209191-23-014589
Insider Transaction Report
Form 4
Delaney Brendan
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2023-03-01+235,000→ 235,000 totalExercise: $10.93Exp: 2033-03-01→ Common Stock (235,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001722585
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:05 PM ET
- Size
- 6.2 KB